Clinical trial
A Pivotal Multicenter Trial of Moxetumomab Pasudotox in Relapsed/ Refractory Hairy Cell Leukemia
NCT01829711 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pivotal Multicenter Trial of Moxetumomab Pasudotox in Relapsed/ Refractory Hairy Cell Leukemia
- Lead sponsor
- MedImmune LLC
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 29, 2013
- Completion date
- April 29, 2019
- Enrollment
- 80 (actual)
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.